Efficacy of Breast Milk Expressed and Sucrose in Procedural Pain in Preterm (LACTEET)
Pain, Premature Infant, Human Milk
About this trial
This is an interventional treatment trial for Pain focused on measuring pain, premature infant, sucrose, breastfeeding, expressed breast milk, PIPP
Eligibility Criteria
Inclusion Criteria:
- Preterm neonates.
- Weight less than 2500 grams.
- Feed breastfeeding (exclusive or not) or can obtain weight expressed breastmilk .
- Be informed and consent to the parents of those infants previously requested.
Exclusion Criteria:
- Maternal use of opioids or insulin-depent
- infants with invasive artificial respiration
- infants with major congenital anomalies
- infants with grade II or IV intraventricular hemorrhage or strokes
- receiving parental sedatives or vasoactive drugs
- infants with necrotizing enterocolitis
- with surgical interventions
- infants in absolute diet
- infants with abstinence syndrome
Sites / Locations
- Hospital University Gregorio Marañon
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
expressed breast milk
sucrose 24% oral
A single dose of expressed breast milk was administered through a sterile syringe in the mouth 2 minutes before venopuncture to neonates, accompanied at all times provided the technique allows it to non-nutritive sucking and containment. The doses administered: 0.1ml in infants less than 27 weeks , 0.25 ml for infants 27-31 weeks , 0.5 ml for infants 32-37 weeks.
A single dose of sucrose was administered through a sterile syringe in the mouth 2 minutes before venopuncture to neonates, accompanied at all times provided the technique allows it to non-nutritive sucking and containment. The doses administered: 0.1ml in infants less than 27 weeks , 0.25 ml for infants 27-31 weeks , 0.5 ml for infants 32-37 weeks.